Chinese english Germany Japanese Korea

3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane)

3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane) Struktur
332024-77-8
CAS-Nr.
332024-77-8
Englisch Name:
3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane)
Synonyma:
Spiro[benzo[h]quinazoline-5(3H),1'-cyclopentan]-4(6H)-one, 3-(2-phenylethyl)-2-[(phenylmethyl)thio]-;3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane)
CBNumber:
CB31975003
Summenformel:
C31H30N2OS
Molgewicht:
478.65
MOL-Datei:
332024-77-8.mol
Request For Quotation

3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane) Eigenschaften

Siedepunkt:
663.3±65.0 °C(Predicted)
Dichte
1.21±0.1 g/cm3(Predicted)
pka
-2.01±0.20(Predicted)

Sicherheit

3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane) Chemische Eigenschaften,Einsatz,Produktion Methoden

3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Specs --
 info@specs.net The Netherlands 6835 70
  • 3-(2-phenylethyl)-2-[(phenylmethyl)sulfanyl]-5,6-dihydro-4(3H)-oxospiro(benzo[h]quinazoline-5,1'-cyclopentane)
  • Spiro[benzo[h]quinazoline-5(3H),1'-cyclopentan]-4(6H)-one, 3-(2-phenylethyl)-2-[(phenylmethyl)thio]-
  • 332024-77-8
Copyright 2019 © ChemicalBook. All rights reserved